CUSIP 12529R107COM STKCCCCQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
100 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 9.44M | $18.03M | +9.44M | New |
| 2 | Morgan Stanley | 8.98M | $17.15M | +4.01M | Added |
| 3 | Ra Capital Management, L.P. | 8.00M | $15.28M | +8.00M | New |
| 4 | Bain Capital Life Sciences Investors, LLC | 7.17M | $13.70M |
| +6.06M |
| Added |
| 5 | Lynx1 Capital Management LP | 7.10M | $13.56M | 0 | Held |
| 6 | Vanguard Group Inc | 4.38M | $8.37M | +1.19M | Added |
| 7 | Wasatch Advisors LP | 4.34M | $8.30M | −507.8K | Reduced |
| 8 | Soleus Capital Management, L.P. | 3.80M | $7.27M | −3.25M | Reduced |
| 9 | Bank Of America Corp /De/ | 2.39M | $4.56M | +334.4K | Added |
| 10 | Silverarc Capital Management, LLC | 1.99M | $3.81M | +96.8K | Added |
See every fund holding C4 Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders